Metraipolis › archive › dc_02f5e12ca93f

Bedaquiline resistance: a predictable consequence of a game-changing drug? — Europe PMC PMID:42416845

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42416845
DOI
10.1128/asmcr.00228-25
License (as archived)
solo-consultazione
Archived
2026-10-06T09:10:52.814Z
SHA-256 of the archived text
3d51528844e1675078d1da9ccdd1abfa1ea291142063f78b3915a96c82a563a2
Stable URL of this page
https://metraipolis.com/documento/dc_02f5e12ca93f

How to cite

Bedaquiline resistance: a predictable consequence of a game-changing drug? — Europe PMC PMID:42416845 — Europe PMC (en), https://europepmc.org/article/MED/42416845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02f5e12ca93f (Metraipolis archive dc_02f5e12ca93f, sha256 3d51528844e1675078d1da9ccdd1abfa1ea291142063f78b3915a96c82a563a2)
BibTeX
@misc{dc02f5e12ca93f,
  title = {Bedaquiline resistance: a predictable consequence of a game-changing drug? — Europe PMC PMID:42416845},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42416845},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02f5e12ca93f; sha256 3d51528844e1675078d1da9ccdd1abfa1ea291142063f78b3915a96c82a563a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42416845. Agents can read the archived copy with the MCP tool read_document.